Description of Activities

Description of transaction: The proposed transaction forms part of a larger restructuring of the respective interests of (i) Remgro Limited (“Remgro”) and (ii) MSC Mediterranean Shipping Company SA (“MSC Holding”) (through its wholly owned subsidiary Investment Holding Limited S.à.r.l. (“IHL”)) in Mediclinic Holdings Limited (“Mediclinic Holdings”). Currently Remgro and IHL each jointly control Mediclinic Holdings. Following the implementation of the proposed transaction, Remgro will transition from indirectly jointly controlling MCSA to sole control.

Acquiring group: The primary acquiring undertaking is RHH, a South African incorporated entity controlled by Remgro, a public company listed on the JSE. Aside from its joint control of the target undertaking, Remgro also indirectly controls Wispeco Holdings Proprietary Limited, which indirectly controls Namibia Extrusions (Proprietary) Limited. Remgro is a diversified investment holding company whose interests consist mainly of investments in healthcare, consumer products, financial services, infrastructure, and industrial sectors. Wispeco supply and distribute aluminum extrusions and related hardware utilized in the manufacturing of aluminum products. Furthermore, the acquiring group does sell products in Namibia related to pies, pet food, and grocery products under RCL Foods Limited and a variety of industrial and specialty gas products under Air Products South Africa Proprietary Limited.

Target undertaking: The primary target undertaking is MCSA, a South African incorporated entity controlled by Mediclinic Holdings, which is in turn ultimately jointly controlled by MSC Holding and Remgro. MCSA controls several entities in Namibia, forming part of the Mediclinic Group. Mediclinic Holdings is a diversified international private healthcare services group established in South Africa, with divisions in Switzerland, South Africa, Namibia, and the Middle East. MCSA indirectly owns and operates 3 multi-disciplinary hospitals in Namibia. Additionally, under Mediclinic, the target owns a sub-acute and guesthouse facility.

Relevant market: The merging parties submit that the relevant market is that of the provision of private hospital services in Namibia. 

Submit Your Comments

The Namibian Competition Commission (NaCC) values your input in ensuring fair competition across the country. If you have concerns about a business practice, merger, or market behavior, simply fill out our Feedback Form below. Provide a brief description of your concern, and include any relevant details or documentation. Your submission will be reviewed confidentially, and we’ll follow up if further information is needed.

Submission Form